Michael Adatto
Corporate Officer/Principal bei Horizon Therapeutics USA, Inc.
Ursprung des Netzwerks ersten Grades von Michael Adatto
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Horizon Pharma, Inc.
 Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.
11
| Extinct | Pharmaceuticals: Major | 11 |
Horizon Therapeutics USA, Inc.
 Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics USA, Inc. develops prescription drugs for mild to moderate pain relief arthritis. The company is headquartered in Northbrook, IL.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Adatto
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMCOL INTERNATIONAL CORPORATION | Construction Materials | Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Founder | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MEDICINOVA, INC. | Pharmaceuticals: Major | Chairman | |
| COMPLETE GENOMICS, INC. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
Ception Therapeutics, Inc.
 Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor | |
| The University of Nottingham | College/University | Undergraduate Degree | |
Essex Woodlands Health Ventures LP
 Essex Woodlands Health Ventures LP Essex Woodlands Health ventures Fund LP invests in startups and buyout stage industries and also focus in the areas like Pharmaceuticals, Biotechnology, Medical Devices, Health Services, Managed Care and Health Information. | Corporate Officer/Principal | ||
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | President | |
| Biochem Therapeutic, Inc. | President | ||
| VisioMedtrics, Inc. | Director of Finance/CFO | ||
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman | |
TeneoBio, Inc.
 TeneoBio, Inc. Miscellaneous Commercial ServicesCommercial Services TeneoBio, Inc. operates as a biotechnology company that develops biologics, human heavy chain antibodies, as therapeutics against cancer, autoimmunity, and infectious diseases. Its products provides treatment of multiple myeloma, prostate cancer, immune disorders, and AIDS. The company was founded by Roland Buelow, on August 9, 2009 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
NexEos Diagnostics, Inc.
 NexEos Diagnostics, Inc. Medical/Nursing ServicesHealth Services NexEos Diagnostics, Inc. operates as a medical diagnostics company focuses on disorders related to white blood cells. The company is headquartered in Wayne, PA. | Medical/Nursing Services | Director/Board Member | |
| ASSERTIO HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Sorriso Pharmaceuticals, Inc.
 Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Director/Board Member Chairman | |
NexEos Bio, Inc.
 NexEos Bio, Inc. Medical/Nursing ServicesHealth Services NexEos Bio is a medical diagnostics company that aims to improve the detection, diagnosis, treatment, and management of patients with chronic, eosinophil-related inflammatory diseases. The company is based in Wayne, PA. The company's lead program is a non-invasive imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE). This program has the potential to improve patients' quality of life, more rapidly diagnose their disease, and may help delay disease progression. The company was founded by Gerald Gleich, and the CEO is Theresa Mansi. | Medical/Nursing Services | Director/Board Member | |
Seed-One Ventures LLC
 Seed-One Ventures LLC Investment ManagersFinance Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina. | Investment Managers | Founder |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 5 |
| Kanada | 3 |
| Irland | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 34 |
| Finance | 5 |
| Health Services | 4 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Operativ
| Director/Board Member | 138 |
| Independent Dir/Board Member | 45 |
| Corporate Officer/Principal | 39 |
| Chairman | 33 |
| President | 24 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Michael Grey | 32 |
| Louis C. Bock | 27 |
| Hubert Birner | 27 |
| Gino Santini | 26 |
| Jeff Himawan | 24 |
| George Tidmarsh | 22 |
| Jeffrey Sherman | 21 |
| Ronald E. Pauli | 15 |
| Robert J. de Vaere | 12 |
| Todd Smith | 11 |
| Paul M. Palz | 8 |
| Kathleen Andersen | 3 |
| Jeannie McGuire | 3 |
| Ben Bove | 3 |
- Börse
- Insiders
- Michael Adatto
- Unternehmensverbindungen